Medtronic broke all time highsWith the market down today, MDT doesn't care... It's breaking tested, heavy resistance at all time highs.
Technicals look great as well.
*Check chart for more info*
Health
BIOMARIN - GOOD BUY OPPORTUNITYToday we gonna look at the pharmaceutical company, as a potential new giant trend on the stock market. NASDAQ:BMRN laying on the strong support line near $87.87 and can move up suddenly. My recommendation:
1. Buy now around 87.87
2. Take profit: 109.45
3. SL: 78.68
Risk/Reward - 2.39, potential profit - 24,6%
LONG USD/TRYFreehand drew the health and momentum of the two previous waves, both seem to be improving. I charted color coded lines based upon highs and lows from different timeframes. Using those as entry and exit points. 6.2439 is my stop buy with a take profit at 7.0412.
$CVS Triple bottom playing outThe tripple bottom i spotted is playing out nicely, some little but safe % have been made, tomorrow earnings :D
Bullish Trajectory for AMRS - ReportAMRS has been on a downward spiral for the last couple of years, but within recent time thcompany is pledging towards creating an effective approach towards future advancements. While also presenting at the paradigm capital biosynthesis conference on April 15th in Toronto. (Source Yahoo Finance)
Not investment advice. For personal and educational purposes only. (I am attempting to utilize a less indicator approach and more so price action). Any tips would be greatly aappraciated. Thank you
WHERE WILL BTC STOP ITS UPTREND?Btc can stop trending at any time. Price actually hitting the resistance highlighted in the chart isn't a guaranteed thing, though it will act as a significant pivot. Most likely price will be rejected off of the 1.25 standard deviation of the longest over expanded period (which at this time is the 530 period.)
If price DOES go over that pivot, price will revert fully to the 530 moving average with very high probability.
The indicator shown is 3D WAVE PM. It is designed to display 128 separate periods of distributional width (how wide the standard deviations on a bellcurve are relative to each other,) and represented as a. heatmap. With this reading, you can find the most significant pivots for sustainable growth to identify the two major market conditions, "trending" and "not trending."
Want to learn more about trading with mass as a metric? Find more resources below.
($BHC )Bausch health (VRX) jammed triangle Simple update today for ex-Valeant (VRX) now Bausch Health. We have a a triangle with squeezed volatility. Positions can me taken once the edges will be broken. As for now we are really closed to the lower line at 22,26 dollars.
At the moment watch and wait would be the most logic solution. Aggresive traders can take long position with SL lower than 22, 26, but it might be somewhat risky (because secondary main trand is bearish). RSI is quite down but at the moment there are no divergences suggesting a trend inversion (bullish).
Ascending wedge, expect fall to 235Long term trend line and ultimate bottom trend. Ascending wedge pattern still being respected.
Short term bull, medium term bear (correction), followed by continued up movement along trend
Valor intrínseco CVSCompañía medica, valor intrínseco calculado a partir de crecimiento en ventas, manejo de deuda, potencial de crecimiento futuro y comparación con otras compañías del sector.
PTOY LONG HODL Get it while it's hot!This company is going places, I have been researching the team, the fundamentals, and TA for about a week or two for a few hours every day. The entirety of the staff checks out and they have built a HIPPA approved platform to interface with EMR companies. This will revolutionize healthcare as we know it, they have a free app coming out this month for patients to interface with their care team as well as other individuals with similar conditions. They have been chosen to present at a convention in Atlanta October 2017, have been picked multiple times in multiple places one of the top ten most influential companies, not even at events solely restricted to the crypto space...top ten out of hundreds of other companies. This will disrupt healthcare IT as we know it! They are also doing a trial at 8 hospitals for ninety days. This will climb throughout that time and if even one of those 8 hospitals signs on after the 90 day trial that will send it flying. I have connections in the healthcare space, (specifically pharmaceuticals and EMR) and I have showed them this company and their plan of action and they agree that it is a winner. Oh did I mention they are HIPPA compliant, yes I did, but that is HUGE. My understanding is that they can interface with current EMR companies as well as having the technology to possibly replace them down the road. My understanding is they are also aligned with Kaiser Permanente which is almost enough right there. If you have a little more time than I have taken already there is a great analysis on medium that I cannot take credit for.
medium.com
Writing this I feel like a schill but this is far from the truth, I have bought in 3x and plan to as much more as I can, my family is and my friends are. This one is a win that I may not ever let go of.
If we break 10k PTOY might moon hardmost good bittrex coins have in the last week mooned, ptoy is destined to do that too. Will it happen today? we will see
Long term this one is a winner, you will become rich
$IDXG On a Clear Breakout with Potential News Down Pipeline$IDXG Latest Insider Purchases, Institutional Ownerships and News:
2016-02-03 Glorikian Harry Director Acquired 127,696
2016-02-03 KEEGAN JOSEPH D Director Acquired 127,696
2016-02-03 STOVER JACK E Interim President and CEO Director Acquired 294,756
2016-02-03 SULLIVAN STEPHEN J Director Acquired 295,656
2017-06-23 SC 13G ARMISTICE CAPITAL, LLC Acquired 965,784
John P. Dugan (Founder): 4,869,878 common shares
Other Insiders Approximately: 2,672,149 shares collectively
Total Insiders: 7,542,027 shares
Institutional Ownership: 30.6% 5.5 mil shares (Increased to 6.5 mil as of June 23rd)
Largest Institutional Holder: Heartland Advisors: 2,994,313
Recent News Headlines:
2017-06-28 Interpace Diagnostics Announces National Contract With Aetna
2017-06-26 Interpace Diagnostics Announces Coverage Of Thyroid Test By Premera Blue Cross
2017-06-16 Interpace Diagnostics Announces Pricing Of $13.7 Million Underwritten Public Offering Of Common Stock And Common Warrants
2017-06-06 Interpace Diagnostics Announces Agreement With Einstein Medical Center Of Philadelphia
2017-05-25 Interpace Diagnostics Announces Launch Of Enhancement To Thyroid Testing Services
2017-05-16 Interpace Diagnostics Group's (IDXG) CEO Jack Stover on Q1 2017 Results - Earnings Call Transcript
2017-05-15 Interpace Diagnostics To Host Conference Call And Webcast To Discuss First Quarter 2017 Financial Results On Monday May 15, 2017
2017-05-10 Interpace Diagnostics Presents New Data on PancraGEN® at DDW
2017-04-20 Interpace Diagnostics Eliminates Long Term Secured Debt
2017-04-18 Interpace Diagnostics Announces Coverage Of ThyraMIR With UnitedHealthcare
2017-04-13 Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement
2017-04-04 A Look at Interpace Diagnostics Financials, Drug Pipeline and Market Opportunity
2017-04-03 Interpace Diagnostics Announces European Patent Approval For Underlying Technology Of Its Thyramir Microrna Classifier
VDRM Brings in Ivan Klarich" ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has hired Mr. Ivan Klarich, who is an expert in managing the launching of "Go to Market" strategies for new product compliance. The Company wants to avoid the pitfalls often found in the launching a new product or product line. The Company wants to assure a solid strategy behind the launch for the labeling, marketing and distribution. The "Quality Control" plan will assure the product meets strict guidelines, starting with the manufacturer all the way through to the point of purchase. The Company plans to continue to hire several experts in the specialty pharmaceutical field as the Company rolls out an aggressive growth plan for 2017 and the years ahead."
Very excited for this PR and what it means for the long run for VDRM. Anyone who has been following my posts knows I'm very long long on this company in 2017.
I think we may see a 20% green day today, but even if we continue to go back down a bit I have no worries and will continuing buying more.
VDRM long and strong!
Millionaires will be made
pennies to thousands above cloud good volumecci and percent r upper range read in our book on amazon important reasons why-relative strength good-ax good-stop loss below 50 ma-stoc strong-above 50-money flow good-diversify-look for 200 day ma enter on good 21 minute candle
Canopy Growth Corp. Stock PricesThis shows the stock prices of Canada's largest medical marijuana company.
Canopy Growth Corp. Stock Prices This tracks Canada's largest medical marijuana company's stock prices.
Almost Family Does 38.2% RetracementAlmost Family has done a 38.2% Fibonacci Retracement.
Almost Family has grown EPS by +1340% quarter over quarter, and EPS forecasts for this company are rising fast.
This company has had an EPS surprise for the last 8 quarters!
The company has an excellent P/S of 0.8.
The catalyst for growth is that Americans are living longer and that means more home health care services are needed.
According to a 2014 report by Transparency Market Research, the global home health care market is expected to explode to $303.6 billion in 2020, up from $176.1 billion in 2013, growing at a compound rate of more than 8% per year.
Source: www.guerillastocktrading.com
COKE - ShortShorting Coca-Cola bottling company.
Why?
Price is near 52 week high.
Recent strong rally in price, on no news.
Price stopped accelerating upward, slowing/stopping (bulls are done).
Consumer sentiment for sugary beverages continues to fall.
Biggest sales are Europe which is currently burning the Euro.
Price targets
* 100
* 91
I'm not confident on the price targets, but I am fairly confident on the overall direction turning from up to down.
US Market Sideways to Downside Risk in 2015Intermarket Study for 2014
Utilities - XLU - and Health Care - XLV - Outperformed in 2014, and these two sectors saw the biggest % gains later in the year. Health Care and Utilities are considered economically insensitive sectors, and tend to outperform when the market is at risk of a pullback or a sideways markets. Historically, economically-sensitive sectors like consumer cyclical, industrial and energy stocks tend to outperform the stock market in a healthy uptrend.
